Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy

Leyva, F.; Foley, P. W. X.; Stegemann, B.; Ward, J. A.; Ng, L. L.; Frenneaux, M. P.; Regoli, F.; Smith, R. E. A.; Auricchio, A.
October 2009
Heart;Oct2009, Vol. 95 Issue 19, p23
Academic Journal
Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT). Design: Prospective cohort study. Setting: District general hospital. Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35%) who underwent CRT. Interventions: CRT device implantation. Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure. Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25%) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3-5; HR: 11.1 (95% confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (≥5; HR: 30.5 (95% CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model. Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT.


Related Articles

  • Encuesta Nacional del Tratamiento y Control Metabólico y de los Factores de Riesgo Cardiovascular de los pacientes con diabetes mellitus tipo 2, atendidos por especialistas en Medicina Interna. de la Peña, Jorge Escobedo; Reyes, Joaquín Reinoso; Gómez, Lucía Flores; Gracida, Leonardo Olvera; Melgar, Pablo Heredia; Madrigal, Jaime Carranza; Aguilar Guerra, José Luis; Villegas Pichardo, Luz Odette; Vidales Rosales, José Antonio; Landaverde, Anaid Ruiz; Paz Barreiro, José Andrés; Bernal Estrada, José Enrique; Ruiz Torres, Juan Carlos; Domínguez Leal, Luis Enrique; Ramos Barajas, José Luis; Valentín García, José Man // Medicina Interna de Mexico;sep/oct2010, Vol. 26 Issue 5, p449 

    No abstract available.

  • When Does Heart Disease Begin? Hollander, Dore // Family Planning Perspectives;Jan/Feb97, Vol. 29 Issue 1, p4 

    This article focuses on heart diseases. Mortality from cardiovascular disease is associated with low birth weight, and patterns of fetal growth may determine the type of disease that develops. Of 13,249 British men born between 1907 and 1930, 230 died of stroke, and 1,409 died of coronary heart...

  • Decreased Glomerular Filtration Rate Is Associated with Mortality and Cardiovascular Events in Patients with Hypertension: A Prospective Study. Rui Zhang; Liqiang Zheng; Zhaoqing Sun; Xingang Zhang; Jue Li; Dayi Hu; Yingxian Sun // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: Few studies reported the associations between decreased glomerular filtration rate (GFR) and mortality, coronary heart disease (CHD), and stroke in hypertensive patients. We aim to assess the associations between GFR and mortality, CHD, and stroke in hypertensive patients and to...

  • Deaths from heart disease in decline.  // Australian Nursing Journal;May2009, Vol. 16 Issue 10, p24 

    The article discusses the declining death rate from cardiovascular disease (CVD) and coronary heart disease (CHD) in Australia. A report by the Australian Institute of Health and Welfare (AIHW) indicated that CVD and CHD death rates have declined since the 1960s. However, the leading cause of...

  • Sudden cardiac death athletes: a systematic review. Ferreira, Marcelo; Santos-Silva, Paulo Roberto; de Abreu, Luiz Carlos; Valenti, Vitor E.; Crispim, Vanessa; Imaizumi, Caio; Filho, Celso Ferreira; Murad, Neif; Meneghini, Adriano; Riera, Andrés R. Pérez; de Carvalho, Tatiana Dias; Vanderlei, Luiz Carlos Marques; Valenti, Erica E.; Cisternas, José R.; Filho, Oseas F Moura; Ferreira, Celso // SMARTT: Sports Medicine, Arthroscopy, Rehabilitation, Therapy & ;2010, Vol. 2, p19 

    Previous events evidence that sudden cardiac death (SCD) in athletes is still a reality and it keeps challenging cardiologists. Considering the importance of SCD in athletes and the requisite for an update of this matter, we endeavored to describe SCD in athletes. The Medline (via PubMed) and...

  • Perioperative use of atoravasatin reduced cardiovascular events in patients having vascular surgery.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p64 

    The article addresses the question whether in patients having vascular surgery, perioperative use of atorvastatin reduces cardiovascular events. In patients having vascular surgery, perioperative use of atorvastatin reduced the composite endpoint of cardiovascular events (death from cardiac...

  • Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure. Demers, Catherine; McMurray, John J. V.; Swedberg, Karl; Pfeffer, Marc A.; Granger, Christopher B.; Olofsson, Bertil; McKelvie, Robert S.; Östergren, Jan; Michelson, Eric L.; Johansson, Peter A.; Wang, Duolao; Yusuf, Salim // JAMA: Journal of the American Medical Association;10/12/2005, Vol. 294 Issue 14, p1794 

    Context Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI), but it is not known whether angiotensin receptor blockers have the same effect. Objective To assess the impact of the angiotensin receptor blocker candesartan on MI and other coronary events in...

  • UTILIDAD DEL RIESGO CARDIOVASCULAR EN LA PREDICCIÓN DE LA ENFERMEDAD ARTERIAL CORONARIA. Base, Abel Ventura; Aportela, Ronald Aroche; Rodríguez Navarro, Ángel Yaniel // CorSalud;2011, Vol. 3 Issue 2, p59 

    Introduction and Objectives: Heart disease is the leading cause of death in Cuba. Currently, the assessment of the extent and severity of coronary lesions is performed through invasive and expensive methods. The purpose of this research was to determine the usefulness of total cardiovascular...

  • Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. Watson, Karol E.; Harmel, Anne L. Peters; Matson, Gary; Peters Harmel, Anne L // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2003, Vol. 8 Issue 4, p253 

    Type 2 diabetes mellitus is associated with a marked increase in the risk of atherosclerotic diseases, including coronary heart disease, peripheral arterial disease, and cerebrovascular disease. Insulin resistance is a key factor in the pathogenesis of type 2 diabetes mellitus. Insulin...


Read the Article


Sign out of this library

Other Topics